Polaris Partners
Funding rounds backed by Polaris Partners.
- Funding disclosed in full
- $251M
- Median round
- $63.5M
- Rounds in calculation
- 4
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Tavo Biotherapeutics Develops novel therapeutics for glaucoma and retinal diseases | $17MSeries A | BiotechUnited States | |||
| Crossbow Therapeutics Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers | $77MSeries B | BiotechUnited States | |||
| TRex Bio Develops precision immunoregulatory medicines based on tissue Treg biology | $50MUndisclosed | BiotechUnited States | |||
| EpiBiologics Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo... | $107MSeries B | BiotechUnited States |